Executive Director, Global Market Development

Key Responsibilities:
- Develop and execute a global KOL engagement strategy for Friedreich’s Ataxia (FA).
- Build relationships with neurologists, cardiologists, geneticists, and FA experts globally.
- Map treatment centers, hospitals, and academic institutions.
- Partner with Medical Affairs and Opinion Leader Programming to generate actionable insights.
- Execute advisory boards and scientific engagements; represent Solid at global congresses.
- Support clinical site identification and readiness.
- Ensure compliance with global regulatory standards.

Qualifications:
- Advanced degree (MD, PhD, PharmD, or equivalent) preferred.
- 15+ years in biotech/pharma with demonstrated global KOL experience.
- Rare disease or neuromuscular expertise preferred.
- Experience in European markets required.
- Gene therapy and clinical development knowledge required.
- German and/or French fluency preferred.
- Ability to travel 40–60%.

Key Attributes:
- Strategic and externally oriented; strong relationship builder; executive presence.
- Entrepreneurial mindset; highly collaborative.

Benefits (as listed):
- Health and dental (FSA/HSA), 401(k) with company match, employee stock purchase plan.
- Mobile phone subsidy, tuition reimbursement, vision coverage, life insurance.
- Voluntary pet insurance; employee discount program.
- Onsite: subsidized lunch, onsite gym, employee parking (Hood Park).

Remote: U.S. or Europe-based candidates; significant international travel required.